Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Search for stocks (e.g., AAPL, GOOGL, AMZN)
ACRS logo

ACRS

NGS
Aclaris Therapeutics Inc.
HealthcareBiotechnology
Watchlists:
Last updated: Friday 11th July 2025
1.59
+0.05 (3.25%)
Prev Close:1.54
Open:1.61
Bid:1.55
Ask:1.64
52 Week Range
1.05
5.17
Volume:901,548
Mkt Cap:157 M
Price Target
$1.83
+15.1%
Metrics

Growth

EPS
QoQ
N/A
YoY
N/A
Revenue
QoQ
N/A
YoY
N/A
Free Cash Flow
QoQ
N/A
YoY
N/A

Peers

Peers data not available
Available data keys: fn_01356, peerValues

Risk

Financial Health

Liquidity Ratios
Financial Scores

Technicals

Technical Oscillators
Volatility Metrics
Financials

Financial Statements

ACRS - Income Statement (Annual)

Dec-24Dec-23Dec-22Dec-21Dec-20Dec-19Dec-18Dec-17Dec-16Dec-15
Accretion On Preferred Stock3 M
Basic Discontinuous Operations-1.16
Depreciation And Amortization700000.0800000.0700000.0800000.01 M2 M-1 M-370000.0-120000.0-90000.0
Development Expense4 M
Diluted Discontinuous Operations-1.54
Gain On Sale Of PPE200000.0
Gain On Sale Of Security487000.0678000.0152000.089000.0
Gains Loss On Disposal Of Discontinued Operations139000.01 M-552000.0
General And Administrative Expense22 M32 M25 M24 M21 M28 M26 M19 M15 M5 M
Gross Profit Margin (profit Margin After CGS)3 M28 M18 M2 M1 M172000.02 M476000.0
Impairment Of Capital Assets19 M
Interest Expense Non Operating4 M5000.087000.0
Misc Other Special Charges2 M9 M3 M-1 M-424000.0-2 M3 M2 M488000.0104000.0
Net Income (loss)-132 M-88 M-87 M-91 M-51 M-161 M-83 M-69 M-48 M-21 M
Net Income Common Stockholders-132 M-88 M-87 M-91 M-51 M-114 M-83 M-69 M-48 M-23 M
Net Income Continuous Operations-132 M-88 M-87 M-91 M-51 M-161 M-83 M-69 M-48 M-21 M
Net Income Discontinuous Operations-285000.0-63 M-552000.0
Net Non Operating Interest Income Expense8 M9 M-4 M-5000.0-87000.0
Operating Income-142 M-97 M-90 M-90 M-51 M-111 M-85 M-72 M-49 M-21 M
Operating Income Before Depreciation (EBITDA)-131 M-88 M-84 M-64 M-47 M-107 M-80 M-70 M-48 M-20 M
Operating Expense56 M131 M103 M67 M50 M93 M87 M-73 M-49 M-21 M
Other Gain Loss From Disposition Of Discontinued Operations424000.014 M
Other Gand A22 M32 M25 M24 M21 M28 M26 M19 M15 M5 M
Other Impairment Of Capital Assets7 M4 M-216000.0-289000.0
Other Operating Expenses1 M1 M1 M1000000.0-139 M-73 M-49 M-21 M
Otherunder Preferred Stock Dividend3 M
Preferred Stock Dividends3 M
Promotion And Advertising4 M
Rent And Landing Fees26 M19 M15 M5 M
Research Expense34 M98 M78 M44 M29 M65 M61 M40 M33 M15 M
Restructring And Mn A Income100000.03 M
Salaries And Wages-17 M-14 M-6 M-891000.0
Selling And Marketing Expense5 M170000.014 M
Selling Expense170000.014 M
Total Income Available For Interest Expense (EBIT)-132 M-89 M-85 M-65 M-49 M-113 M-82 M-70 M-48 M-21 M
Total Revenues19 M31 M30 M7 M6 M4 M6 M2 M
Total Expenses71 M134 M115 M72 M55 M97 M82 M-74 M-49 M-21 M
Total Revenue19 M31 M30 M7 M6 M4 M6 M2 M
Write Down5 M
Amord75000.075000.07 M7 M518000.0-75000.0-31000.0
Avgshs77 M70 M65 M57 M43 M41 M33 M28 M21 M6 M
Avgshsdt77 M70 M65 M57 M41 M21 M28 M21 M5 M
Basiceps-1.71-1.27-1.33-1.6-1.2-3.9
Basicepscont-1.71-1.27-1.33-1.6-1.2-3.9
Cor15 M3 M12 M5 M5 M4 M-4 M-1 M
Depamor700000.0800000.01 M2 M-1 M-370000.0-120000.0-90000.0
Dileps-1.71-1.27-1.33-1.6-1.2-3.9-4.03-2.44-2.25-3.79
Dilepscont-1.71-1.27-1.33-1.6
Intinc8 M9 M
Netincdisc-132 M-88 M-87 M-91 M-51 M-161 M-83 M-69 M-48 M-21 M
Othincexp586000.0-27 M-2 M25 M3 M7 M-3 M-2 M-488000.0-104000.0
Pretaxinc-132 M-89 M-87 M-91 M-51 M-114 M-82 M-70 M-48 M-21 M
Resdev34 M98 M78 M44 M29 M65 M61 M40 M33 M15 M
Restruct100000.03 M
Sga22 M32 M25 M24 M21 M28 M26 M33 M15 M5 M
Shsout108 M71 M67 M108 M52 M42 M41 M31 M26 M20 M
Specincchg-3 M-3 M-100000.0-19 M
Taxprov-367000.0-182000.0-2 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement "your own" investment strategies in Excel with thousands of MarketXLS functions and templates.
MarketXLS provides all the tools I need for in-depth stock analysis. It's user-friendly and constantly improving. A must-have for serious investors.

John D.

Financial Analyst

I have been using MarketXLS for the last 6+ years and they really enhanced the product every year and now in the journey of bringing in AI...

Kirubakaran K.

Investment Professional

MarketXLS is a powerful tool for financial modeling. It integrates seamlessly with Excel and provides real-time data.

David L.

Financial Analyst

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel.

Lloyd L.

Professional Trader